UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000046922
Receipt No. R000052935
Scientific Title A comparative study of the treatment outcome of transanal decompression tube and colorectal stent for stage II/III obstructive colorectal cancer; retrospective multicenter observational study
Date of disclosure of the study information 2022/02/15
Last modified on 2022/12/01 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A comparative study of the treatment outcome of transanal decompression tube and colorectal stent for stage II/III obstructive colorectal cancer; retrospective multicenter observational study
Acronym A comparative study of the treatment outcome of transanal decompression tube and colorectal stent for stage II/III obstructive colorectal cancer; retrospective multicenter observational study
Scientific Title A comparative study of the treatment outcome of transanal decompression tube and colorectal stent for stage II/III obstructive colorectal cancer; retrospective multicenter observational study
Scientific Title:Acronym Outcome of transanal decompression tube and colorectal stent for obstructive colorectal cancer
Region
Japan

Condition
Condition Obstructive Colorectal Cancer
Classification by specialty
Gastrointestinal surgery Operative medicine Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To compare the treatment results of transanal ileus tube and colorectal stent placement for obstructive colorectal cancer.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Relapse Free Survival
Key secondary outcomes Overall Survival, Postoperative Complication

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria 1) 20 to 80 years old
2) Performance status 0-2
3) Histopathologically diagnosed as advanced stage II or III (UICC TNM classification 8th edition)
4) No preoperative chemotherapy or preoperative radiation therapy
5) A transanal decompression tube or colorectal stent was placed before surgery.
6) Radical resection was performed from January 2008 to December 2019.
Key exclusion criteria 1) multiple cancers
2) a history of other cancers within 5 years before surgery
(However, carcinoma in situ or intramucosal cancer, which are considered to be cured by local treatment, do not include)
3) Those with lesions in the lower rectum (Rb)
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Koji
Middle name
Last name Numata
Organization Kanagawa Cancer Center
Division name Gastrointestinal Surgery
Zip code 2418515
Address 2-3-2 Nakao, Asahiku, Yokohama, Kanagawa, Japan
TEL 0455202222
Email koji-numata@hotmail.co.jp

Public contact
Name of contact person
1st name Koji
Middle name
Last name Numata
Organization Kanagawa Cancer Center
Division name Gastrointestinal Surgery
Zip code 2418515
Address 2-3-2 Nakao, Asahiku, Yokohama, Kanagawa, Japan
TEL 0455202222
Homepage URL
Email koji-numata@hotmail.co.jp

Sponsor
Institute Kanagawa Cancer Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kanagawa Cancer Center
Address 2-3-2 Nakao, Asahiku, Yokohama, Kanagawa, Japan
Tel 0455202222
Email koji-numata@hotmail.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 02 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2021 Year 12 Month 22 Day
Date of IRB
2022 Year 01 Month 07 Day
Anticipated trial start date
2022 Year 01 Month 07 Day
Last follow-up date
2022 Year 05 Month 10 Day
Date of closure to data entry
2022 Year 11 Month 30 Day
Date trial data considered complete
2022 Year 12 Month 31 Day
Date analysis concluded

Other
Other related information Retrospective observational study

Management information
Registered date
2022 Year 02 Month 15 Day
Last modified on
2022 Year 12 Month 01 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000052935